Codexis announces CodeEvolver® technology transfer and license agreement with Novartis
Codexis announces the signing of a CodeEvolver® platform agreement with Novartis. Codexis has granted a non-exclusive license to its proprietary CodeEvolver® protein engineering platform technology to Novartis to develop novel performance enzymes for use in manufacturing pharmaceutical products. May 15, 2019